Chemical Stucture (Intuniv 01)
Intuniv Tablet, Extended Release
Product Images NDC 54092-517
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Intuniv (NDC 54092-517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Intuniv 02)
Figure 2 (Intuniv 03)
Figure 3 (Intuniv 04)
Figure 3 (Intuniv 05)
Principal Display Panel (1 mg Tablet Bottle Label)
Principal Display Panel (2 mg Tablet Bottle Label)
NDC 54092-515-02 is a medication called Intuniv (guanfacine) in extended-release tablet form. It is recommended to be stored at a temperature between 20°C to 25°C. Each tablet contains 2 mg of quanfacine and should not be crushed, chewed or broken before swallowing. The medication is distributed by Takeda Pharmaceuticals America, Inc. and made in Spain.*
Principal Display Panel (3 mg Tablet Bottle Label)
intuniv® is a prescription medication containing 3 g of quanfacine HCI as extended-release tablets. The tablets should not be crushed, chewed or broken before swallowing, and should be stored between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). Each bottle of intuniv® contains 100 tablets, and it is distributed by Takeda Pharmaceuticals America, Inc. The text also lists the National Drug Code (NDC) which is 54092-517-02 and the product's tempershee. Made in Spain.*
Principal Display Panel (4 mg Tablet Bottle Label)
Description: This is a label of a medication called Guanfacine Hydrochloride. It contains 100 tablets of 4mg each and should be stored at a temperature between 20°C to 25°C. The medicine should not be crushed or chewed before swallowing. The label mentions the manufacturer's name and the distributor's name.*
Principal Display Panel (NDC 54092-520-01)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
